PerspectivesDevelopment of Neurological Symptoms in Patients with Asymptomatic Cerebral Cysticercosis Undergoing Albendazol Therapy for Intestinal Parasites
References (9)
Medical Treatment of cerebral cysticercosis
Eur Neurol
(1997)- et al.
A prognostic classification of cerebral cysticercosis
J Neurol Neurosurg Psychiatry
(1986) - et al.
Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel
J Neurol Neurosurg Psychiatry
(1989) - et al.
Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy
Neurosurgery
(1983)
There are more references available in the full text version of this article.
Cited by (1)
The dangers of mass drug administration of albendazole in Nepal, a Neurocysticercosis-endemic region
2020, Tropical Diseases, Travel Medicine and Vaccines
Commentary on: Incidental Consequences of Antihelmintic Treatment in the Central Nervous System by Ramos-Zúñiga et al. pp. 149-153.
Mauro Loyo-Varela, M.D., Chairman, Department of Neurosurgery, Hospital Regional Veracruz, Department of Neurosurgery, American British Cowdray Medical Center
Copyright © 2013 Elsevier Inc. All rights reserved.